Imaging-guided photothermal therapy (PTT) has promising application for treating tumors. Nevertheless, so far imaging-guided photothermal drug-delivery systems have been developed with limited success for tumor chemo-photothermal therapy. In this study, as the proof-of-concept, a stimuli-responsive tumor-targeting rapamycin/DiR loaded lipid-polyaniline nanoparticle (RDLPNP) for dual-modal imaging-guided enhanced PTT efficacy is reported for the first time. In this system, polyaniline (PANI) with π-π electronic conjugated system and effective photothermal efficiency is choosed as the appropriate model receptor of fluorescence resonance energy transfer (FRET), and loaded cyanine probe (e.g., 1,1-dioctadecyl-3,3,3,3-tetramethylindotri-carbocyanine iodide, DiR) acts as the donor of near-infrared fluorescence (NIRF). In addition, rapamycin (RAPA), which is used as the antiangiogenesis chemotherapeutic drug, can cutdown the tumor vessels and delay tumor growth obviously. After intravenous treatment of RDLPNPs into Hela tumor bearing mice, fluorescent (from DiR) and enhanced photoacoustic (from DLPNPs) signals were found in tumor site over time, which reached to peak at the 6 h time point. After irradiating with an NIR laser, a good anti-tumor effect was observed owing to the enhanced photothermal and antiangiogenic effect of RDLPNPs. These results show that the multifunctional nanoparticle can be used as a promising imaging-guided photothermal drug delivery nanoplatform for cancer therapy.
Introduction
In the past decade, great efforts have been given to multifunctional nanomaterials that combine diagnostic and therapeutic functions for high-efficient and low-toxicity anticancer therapy. In particular, real-time imaging guided photothermal therapy (PTT) mediated by inorganic or organic nanoparticles responsive to near-infrared (NIR, λ = 700-1100 nm) light through conversion of photo energy into heat has attracted increasing interest due to its simplicity, safety, noninvasiveness as well as targeting and remote-control properties [1] [2] [3] [4] . Therefore, studies in recent years have been designed to identify the most applicable PTT methods, extensively focusing on aspects such as controlling the shape of PTT agents [5, 6] , developing novel materials [7] [8] [9] , the fabrication process [10] , using hybridization methods to enhance the PTT effect [11] , and incorporating photoacoustic (PA) or fluorescence imaging reagents [12] [13] [14] and improving drug loading capabilities and release attributes [15] .
Among various PTT agents, organic nanomaterials have attracted more attentions because the inorganic PTT materials usually are nonbiodegradable with cytotoxic properties and generally would remain in the body for long periods of time after systemic administration [16] . As an organic material, polyaniline (PANI) is potentially one of the most useful conductive polymers [17] [18] [19] [20] . A distinct feature of PANI is that it can switch from the form of emeralidine base (EB) to emeralidine salt (ES) by doping protonic acids, alkali ions, or transition metals and so on ect., which can lead to strong NIR absorption and high conductivity [21] . Until very recently, several studies have reported that PANI nanoparticles can convert NIR light to thermo A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT 4 energy. Thus, they can act as potential photothermal agents [21] [22] [23] . However, PANI nanoparticles alone have limited applications in cancer diagnosis and therapy due to low target to background contrast and poor tumor uptake [22, 24] . Therefore, additional effort is still needed to develop PANI nanomaterials with adequate PTT properties for efficient cancer therapy.
In spite of recent positive progress in the development of diverse photothermal materials [25, 26] , there are only a few solutions to enhance the intrinsic photothermal property of PTT agents due to the lack of strategies to regulate their photothermal conversion efficiency except dimensions and concentrations [27, 28] . So far, the well-engineered photothermal agents for improving imaging guided PTT have not been reported [29] [30] [31] [32] [33] [34] , though stimuli-responsive nanomaterials are widely employed in the functional drug delivery system. Therefore, it is highly necessary to develop a multifunctional photothermal agent using as an efficient drug delivery system to improve the intrinsic photothermal performance and drug release capacity for imaging-guided enhanced PTT and chemotherapy.
Recently, great interests have been devoted to the NIR fluorescent dyes and their nanostructures for imaging guided PTT applications [35] [36] [37] [38] [39] [40] [41] . One representative example is the 1,1-dioctadecyl-3,3,3,3-tetramethylindotri-carbocyanine iodide (DiR) that is a lipophilic fluorescent probe (a subclass of cyanine dyes) with strong absorption in the NIR region and negligible cytotoxicity at low concentration suitable for both in vivo fluorescence imaging and photothermal treatment [42] [43] [44] . DiR has been developed as a particularly promising photothermal candidate because it can A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT 5 convert absorbed fluorescent energy into heat via the non-radiative transition under the NIR laser irradiation. In addition, this type of cyanine dyes can also convert near-infrared fluorescence (NIRF) into thermal energy via radiative transition upon photoirradiation [14] . Due to this distinctive characteristic, the photothermal conversion efficiency of DiR is remarkably enhanced. Interestingly, PANI with π-π electronic conjugated system and broad NIR absorbance can act as a model receptor to receive the NIFR from a donor fluorescent probe such as DiR due to the fluorescence resonance energy transfer (FRET) effect [45] . Therefore, NIRF from DiR would be converted into additional thermal energy when coupled with the PANI nanoparticles to enhance their overall PTT.
In this work, as proof-of-concept, we designed a novel folic acid (FA)-grafted Then the solvent was evaporated at 50℃ at 120 rpm under reduced pressure using rotary film evaporator (Rotavapor, Buchi, Germany). The residual solvent was completely removed in vacuum at room temperature in 12 h. Finally, the thin film that formed on the inner wall of the vial was shattered to nanoparticles by adding 5 mL of phosphate-buffered saline (PBS, pH 7.4) and ultrasonicated for 5 min. The obtained nanoparticles were purified by centrifugation (10,000 rpm for 5 minutes). After that, the suspension was further purified by ultra-filtration through 100 kDa molecular
weight cut off (MWCO) filters. The obtained RDLPNPs could be readily re-dissolved in PBS and was stored for later use. The composition of all the nanoparticles used in this study was shown in the in Supporting Information Table S1 . Drug loading efficiency and drug loading content were calculated according to the formulas:
Drug loading efficiency = amounts of drug in nanoparticles total amount of drug × 100%
Drug loading content = amount of drug in nanoparticles total weight of nanoparticles × 100%
To prepare the DiO-labeled DLPNPs, DiO instead of RAPA was extra added into the chloroform solvent. The other preparation process was the same as described above. The obtained DiO-labeled nanoparticles were dispersed in Dulbecco's modified Eagle medium (DMEM) and kept at 4 °C under darkness for confocal laser scanning imaging.
Characterization
The dynamic diameter of DLPNPs was determined by a Zetasizer Nano-ZS (Malvern Instruments, UK). UV-Vis spectra was measured by a Cary 60 UV-Vis spectrophotometer (Agilent, USA) using quartz cuvettes with an optical path of 1 cm.
Fluorescence spectra of free DiR (in order to increase the solubility of free DiR, 1%
Tween-80 was added into the aqueous solution), DLPNPs, and LPNPs in the aqueous solution were investigated by an LS-55 fluorescence spectrophotometer conditions: i.v. injected with PBS only (PBS); i.v. injected with free RAPA only (Free RAPA); i.v. injected with RDLPNPs only (RDLPNPs); treated with LPNPs and exposed to the laser (LPNPs + NIR); treated with DLPNPs and exposed to the laser (DLPNPs + NIR); and treated with RDLPNPs and exposed to the laser (RDLPNPs + NIR). Tumor volumes were monitored every 2 days for 20 days. On day 8, major organs were collected after treatment and were formalin fixed and processed for routine hematoxylin and eosin (H&E) staining using standard methods. Images were collected using a Nikon light microscope (Nikon).
In Vivo Imaging and Biodistribution Analysis
In vivo fluorescent images of Balb/c mice were taken by using free DiR The sections were also stained by DAPI and covered with a coverslip. The sections were observed using a confocal fluorescence microscope (Leica Microsystems, Heidelberg, Germany). Five randomly selected microscopic fields were quantitatively analyzed on ImageJ (National Institutes of Health).
Statistical Analysis
Results were expressed as mean ± standard deviation (SD). Two-tailed paired and unpaired Student's t tests were used to determine differences within groups and between groups, respectively. P value <0.05 was considered statistically significant.
Characterization of the DLPNPs
Polyaniline (PANI) was synthesized by using anilinium salts protonated by HCl and ammonium persulfate as an oxidant [46] . The chemical oxidative polymerization process was carried out at 4 ℃ for 6 hours to produce a dark-green precipitate, which was purified by washing with amounts of deionized water. This precipitate was dedoped by sodium hydroxide to obtain the purple polymer powder of emeralidine base PANI. The molecular weight of synthesized emeralidine base PANI was 5000 Da, as measured by gel permeation chromatography (polydispersity index: 1.2; Figure S1 in the Supporting Information). In the UV-Vis absorption spectra of emeralidine base PANI in chloroform, charge transfer between quinoid and benzenoid rings was Transmission electron microscopy (TEM) image was used to detected the morphology of DLPNPs (Figure 1a ). As shown in Figure 1c , the average size of DLPNPs was 140.6 nm with a polydispersity of 0.103. An intuitive comparison of DiR, PANI and DLPNPs was represented (Figure 1b) . Free DiR and PANI were scarcely dispersed in water, whereas the as-prepared DLPNPs exhibited considerable water-solubility with a dark green color. To evaluate the stability, DLPNPs was dissolved in PBS and cell culture medium, respectively, and stored at 37 ℃ for 7
days. As shown in Supporting Information Figure S3 and Table S2 , the appearance, sizes, polydispersity index (PDI), and the zeta potentials had no dramatic change. Figure 1d showed the UV-vis absorption spectrum of LPNPs, DLPNPs suspensions in PBS and free DIR dissolved in methanol, respectively. DLPNPs exhibited the absorbance peak at 754 nm, and fluorescence peak at 780 nm, confirming the successful incorporation of DLPNPs (Figure 1d and 1 e ). When the DiR was encapsulated into the LPNPs, DLPNPs exhibited a great increase of absorbance from 600 nm to 810 nm (Figure 1d ). In addition, such an increased absorption of DLPNPs in the NIR region ensured their potential application as the photothermal drug delivery carriers for NIR laser inducing chemo-photothermal therapy. To demonstrate that the attached dye fluorescence could be quenched by LPNPs via FRET, we measured the fluorescence intensities of DiR and DLPNPs. The DiR had showed strong fluorescence intensity in the aqueous solution. When it was encapsulated into LPNPs (forming DLPNPs), however, the attached dyes' fluorescence intensities dropped significantly (Figure 1e ). We further observed that DLPNPs had stronger fluorescence in methanol than that in water, suggesting that DLPNPs obviously quenched in aqueous solution, while recovered in methanol by reason of the high solubility of DiR in methanol ( Figure S4 in the supporting information). Considering the observed dyes' fluorescence quenching, the decreased fluorescence intensity could be due to FRET between DiR molecules and PANI.
Considering that photostability greatly affected UV absorbance of cyanine dye, we investigated the ability of lipid-PANI nanoparticles to enhance the photostability of DiR. UV-Vis spectra showed that free DiR exhibited a decrease of absorbance under 808 nm photoirradiation within 10 min, which may due to its photobleaching (Figure 1h and i). Such a variation of DLPNPs could increase temperature over 50 ℃ after a short period of photoirradiation, which would cause an irreversible thermal ablation of cancer cells [47] . Remarkably, the temperature increase by DLPNPs was around 5 ℃ higher than that of LPNPs indicating additional thermal energy was generated by the FRET effect between DiR and PANI. These results also demonstrated that the broad absorbance of PANI enabled its absorption of most of fluorescence in the NIR region, thus maximizing the conversion efficiency of NIRF into thermal energy.
To investigate RAPA loading capacity of DLPNPs, different amounts of RAPA were loaded into PANI nanoparticles and loading efficiency was calculated (Figure 2a (Figure 3a) . In previous reports from others, it has been revealed that a proper thermal heating could increase the cell membrane permeability without damaging cells, improving the intracellular delivery of drugs [53, 54] . In addition, the heat caused by NIR laser could also induce the thermal vibration of lipid chains of DiO-DLPNPs and thus released more DiO into the cells and nuclei. Considering these factors, it is not surprising that photothermal heating significantly increased the uptake of DiO in both Hela cells and HUVECs.
Next, we tested the cell-killing efficacy of different RAPA formulations in vitro.
In this study, Hela cells and HUVECs were incubated with free RAPA (dissolved in PBS containing 0.5% Tween-80) and RDLPNPs for 24 h, respectively. The RDLPNPs treated cells were irritated by an NIR laser (808 nm, 1.5 W cm −2 , 3 min). The relative cell viabilities were measured by the MTT assay and the results were shown in Figure   S7 . It was found that greater cytotoxicity was induced by higher drug level. At the same drug concentration, it was noted that the RDLPNPs with or without NIR laser significantly decreased the cell survival rate than that of the free RAPA. These results were attributed to the enhanced intracellular RAPA concentration facilitated by the RDLPNPs-mediated cellular uptake. In addition, the cytotoxic effect of chemotherapy, photothermal therapy, and chemo-photothermal therapy on Hela cells and HUVECs treated with PBS, free RAPA, DLPNPs, or RDLPNPs was evaluated respectively (Figure 3b ). Without NIR laser irradiation, the viability of Hela cells and HUVECs
A C C E P T E D M A N U S C R I P T
ACCEPTED MANUSCRIPT 22 treated with DLPNPs was maintained at high rate, confirming that the DLPNPs were virtually nontoxic to Hela cells and HUVECs. Treated with free RAPA (5 μg/mL), however, the cell viability of Hela cells and HUVEC was decreased to 68.3 and 64.5%, respectively, indicating that the RAPA could inhibit the mammalian target of rapamycin (mTOR) pathway and lead to Hela cell and HUVEC death. In addition, the viability of Hela cells and HUVEC in the free RAPA plus NIR laser group was slightly lower than that in free RAPA group, revealing that free RAPA could not produce the photothermal effect under the NIR laser irradiation. Notably, upon NIR irradiation, the cytotoxicity of DLPNPs and RDLPNPs exhibited much pronouncedly increase than that of free RAPA. As the NIR laser irradiation alone did not lead to a decline in Hela cell and HUVEC viability, the observed increase in cytotoxicity could be attributed to the NIR irradiation-induced photothermal ablation and RAPA release mediated by RDLPNPs.
Similar results were also observed in the fluorescence staining of live/dead cells, where most of Hela cells and HUVECs incubated with RDLPNPs plus NIR irradiation presented PI-positive staining due to extensive cell death (Figure 3c ). The results could be attributed to the following two reasons: Firstly, RDLPNPs were presumably internalized by cells in a more effective FA receptors mediated manner, leading to (1) a higher intracellular RAPA concentration comparing with free RAPA;
(2) sufficient amount of PANI which preserved a profound phototriggered ablation effect. Secondly, RDLPNPs with the NIR laser irradiation produced the photothermal heating, which induced more RAPA release from DLPNPs as well as increased the
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In Vivo Fluorescence and Photoacoustic Imaging
We then studied the in vivo biodistribution and tumor selectivity of 
In Vivo Photothermal Imaging
To monitor the in vivo photothermal effect generated by RDLPNPs, an infrared thermal mapping apparatus was used. After 6 h intravenously injection of PBS, free RAPA, RLPNPs, or RDLPNPs (200 μL), respectively, mice bearing Hela tumors were anesthetized and exposed to an 808 nm laser at the power density of 1.5 W cm -2 .
Under irradiation, the tumor surface temperature of mice treated with RLPNPs or RDLPNPs increased from ∼30 to ∼55 ℃ within 5 min, whereas the temperature of the surrounding tissues increased by only 1.3 ℃ ( Figure 5 ). In contrast, the tumor temperature of mice treated with PBS or free RAPA under the same NIR laser irradiation showed little change. These results revealed that our nanoparticles can rapidly raise the tumor temperature through the photothermal effect, which was able to kill both the tumor cells and tumor vasculature endothelial cells.
In Vivo Combinatory Antitumor Activity
Histopathology of various organs and tumor tissues according to H&E staining assay demonstrated that RDLPNPs plus NIR irradiation selectively destroyed the tumor cells without causing noticeable organ damage (Figure 6a and Figure S9 ).
To further evaluate the antitumor efficacy of our nanoparticles, the tumor volume and overall survival of the tumor-bearing mice were assessed (Figure 6b 
In Vivo Antiangiogenesis Effect and Normalized Tumor Vessels
Angiogenesis, the sprouting of new blood vessels from existing parent ones, is crucial for tumor growth, evasion and metastasis [55] . Hence, it plays a key role in the control of tumor progression and become a target to inhibit tumor growth [56] . Unlike the normal blood vessels, the constitute of tumor vasculature is abnormal, resulting in the formation of physiological barriers which hinder the delivery of therapeutic drugs into tumors [57] . Therefore, antiangiogenic imbalances in the tumor results in tumor vasculature normalization and thus improves nanoparticle delivery and accumulation in the tumor [54] . Combination of PTT and chemotherapy during the vascular normalization also exhibits synergistic effects.
To evaluate the anti-angiogenic activity and distribution of RDLPNPs in the Hela tumor, blood vessels were stained by a CD-31 antibody (red color). PBS, free RAPA, DLPNPs or RDLPNPs was injected following the corresponding therapy experiments,
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ACCEPTED MANUSCRIPT 27 and the mice were sacrificed 24 h post intravenous administration (NIR laser was irritated at 6 h). As shown in Figure 7 , mice treated with RDLPNPs with or without NIR laser irradiation resulted in significant increase of nanoparticles accumulation as well as significant decrease in the number of blood vessels in the tumor site. However, 
Conclusion
In conclusion, we have successfully designed and prepared a multifunctional RAPA/DiR loaded lipid-conducted polymer hybrid nanoparticle system, RDLPNPs. It can both effectivly shutdown tumor blood vessels by RAPA and ablate tumor cells through FRET enhanced PTT. Notably, PANI as a receptor of FRET can effectively convert the NIRF energy from the donor DiR resulting in improved PTT efficacy.
RDLPNPs selectively accumulated in tumor sites via the active targeting effect in the triggered by the enhanced photothermal effect after laser irradiation. These results suggested that RDLPNP was a promising photothermal drug delivery nanosystem via an FRET effect, which provided a new strategy to enhance photothermal efficiency for superior imaging-guided chemo-photothermal therapy. Figure 5 . Photothermal images of tumor-bearing mice exposed to the NIR laser (808 nm, 1.5 W cm -2 , 5 min) after intravenous injection with PBS, free RAPA, RLPNPs, or RDLPNPs, respectively. RDLPNPs-injected mice after PTT treatment showed 80% survival ratio over 48 days. (c) Representative photos of a RDLPNPs-injected mouse at day 0 before PTT treatment and at day 10 after treatment. 
